Document:

Exhibit 10.1

Univest Capital Limited
________________________________________________________________________________
Meierhofstrasse 2 FL-9490 Vaduz

December 3, 2005

Mr. Walter Witoshkin
QuantRx Biomedical Corporation
321 Norristown Road, Suite 230
Ambler, PA 19002

Dear Mr. Witoshkin

The purpose of this letter agreement (the "Agreement") is to set forth the
terms and conditions pursuant to which Uninvest Capital Ltd. shall introduce
QuantRx Biomedical Corporation (the "Company") to one or more investors in
connection with the proposed offering (the "Offering") of securities of the
Company. The terms of such Offering and the Securities shall be mutually
agreed upon by the Company and the investors. Uninvest Capital Ltd.
engagement under this Agreement shall be non-exclusive.

In consideration of the services rendered by Uninvest Capital Ltd. under
this Agreement, the Company agrees to pay Uninvest Capital Ltd. the
following fees and other compensation: A cash fee payable upon the closing
of the Offering equal to 8% of the aggregate capital raised by Uninvest
Capital Ltd. and warrants to purchase 8% of the shares to be issued on an as
converted basis of this Offering to the investors introduced by Uninvest
Capital Ltd

This agreement shall be governed by the laws of the State of Pennsylvania,
without regard to conflicts of law principle. Any dispute arising out of
this agreement shall be adjudicated in the courts of the State of
Pennsylvania or in the federal courts sitting in the Eastern District.

This Agreement constitutes the entire understanding and agreement between
the parties hereto with respect to its subject matter and there are no
agreements or understandings with respect to the subject matter hereof which
are not contained in this agreement. If the foregoing correctly states our
agreement, please confirm this by signing and returning to us the duplicate
copy of this letter.

Thank you.

Univest Capital Limited

By: /s/Emst Pernet
    -----------------------------------
    Emst Pernet
    Manager

Agreed to and accepted as of the date first written above:

QuantRx Biomedical Corporation

By: /s/Walter Witoshkin
    -----------------------------------
    Walter Witoshkin
    President & CEOEXHIBIT 10.2

                              BURNHAM HILL PARTNERS
                         A DIVISION OF PALI CAPITAL INC.

370 LEXINGTON AVENUE                                            TEL 212-980-2200
NEW YORK, NEW YORK 10022                                        FAX 212-980-9466

November 8, 2005

Mr. Walter Witoshkin
A-Fem Medical Corporation
321 Norristown Rd. Suite 230
Ambler, PA 19002

Dear Mr. Witoshkin.:

         This agreement confirms the engagement of Burnham Hill Partners, a
division of Pali Capital, Inc. ("BHP") by A-Fern Medical Corporation ("A-Fem" or
the "Company") as its financial advisor in connection with one or more potential
strategic transactions, which may include an acquisition, partnership, strategic
alliance or merger (a. "Strategic Transaction"). In the event the Company elects
to pursue an equity or debt financing during the term of this engagement or an
equity or debt financing is required in connection with a Strategic Transaction,
BHP and the Company shall enter into a separate letter agreement, to be
negotiated in good faith on commercially standard terms, related to such
financing activity. This engagement shall have a term of six months, which term
may be extended upon mutual written agreement of the parties.

As part of BHP's engagement, at the Company's request, BHP will use its
commercially reasonable best efforts to:

     (a)  assist the Company in analyzing and evaluating the business,
          operations and financial position of each suitable prospect for a
          Strategic Transaction;

     (b)  assist the Company with its due diligence efforts related to each
          potential Strategic Transaction;

     (c)  assist the Company in structuring and negotiating each Strategic
          Transaction; and

     (d)  be available at the Company's request to meet with your Board of
          Directors to discuss any proposed Strategic Transaction and its
          financial implications;

     (e)  assist the Company with the identification of potential merger,
          acquisition, partnership or strategic alliance candidates; andassist
          the Company in identifying potential sources of funding.

In connection with BHP's engagement hereunder, the Company shall compensate BHP
as set forth below:

     (a)  Upon execution of this engagement, the Company shall issue to BHP and
          its registered assignees 100,000 common stock purchase warrants
          exercisable at $2.00 per share (the "Advisory Warrants"). The Advisory
          Warrants shall have a term of five years, a cashless exercise
          provision, standard weighted average anti-dilution protection and
          piggyback registration rights.

     (b)  The Company shall pay an advisory of $50,000 to BHP when the Company's
          cash balance exceeds $5,000,000

The Company shall reimburse BHP for out of pocket expenses incurred in
connection with this engagement, subject to a cap of ten thousand ($10,000.00)
dollars.

<PAGE>

         Notice given pursuant to any of the provisions of this Agreement shall
be given in writing and shall be sent by recognized overnight courier or
personally delivered (a) if to the Company, to the address listed above.
Attention: Chief Executive Officer; and (b) if to BHP, to its office at 570
Lexington, 3rd Floor, New York, NY 10022. Attention; Jason Adelman, Managing
Director.

         No financial advice rendered by BHP pursuant to this Agreement may be
disclosed publicly without BHP's prior written approval, except as may be
required by law, regulation or court order.

         This Agreement shall be governed by the laws of the State of New York
applicable to agreements made and to be performed entirely within such State.
The Company may terminate this Agreement upon thirty days written notice to B.

         If any provision of this Agreement is determined to be invalid or
unenforceable in any respect, such determination will not effect such prevision
in any other respect or any other provision of this Agreement. The
Indemnification Agreement attached hereto entered into between, the Company and
BHF shall apply to this engagement.

         Please confirm that the foregoing correctly sets forth our agreement by
signing and returning to BHP the enclosed duplicate copy of this Agreement.

Very truly yours,
Burnham Hill Partners, a division of Pali Capital, Inc.

By: /s/Jason T. Adelman
    --------------------------------------------
    Name:  Jason T. Adelman
    Title: Managing Director

Accepted and agreed to as of the date written above

A-Fem Medical Corporation

By: /s/Walter Witoshkin
    ------------------------------------------
    Name:  Walter Witoshkin
    Title: Chief Executive Officer

<PAGE>

TO: Burnham Hill Partners
    A division of Pali Capital, Inc.                      Date: November 8, 2005
    570 Lexington Avenue
    New York, NY 10022

         In connection with your engagement pursuant to on letter Agreement of
even date herewith (the "Engagement"), we agree to indemnify and hold harmless
Burnham Hill Partners, a division of Pali Capital, Inc. ("BHP") and its
affiliates, the respective directors, officers, partners, agents and employees
BHP and its affiliates, and each other person, if any, controlling BHP or any of
its affiliates (collectively, "Indemnified Persons"), from and against, and we
agree that no Indemnified Person shall have any liability to us or our owners,
parents, affiliates, security holders for, any losses, claims, damages or
liabilities (including actions or proceedings in respect thereof) (collectively
"Losses") (A) related to or arising out of (i) our actions or failures to act
(including statements or omissions made, or information provided, by us or our
agents) or (ii) actions or failures to act by an Indemnified Person with our
consent or in reliance on our actions or failures to act, or (B) otherwise
related to or arising out of the Engagement or your performance thereof, except
that this clause (B) shall not apply to any Losses that are finally judicially
determined to have resulted primarily from your bad faith, willful misconduct or
gross negligence or breach of the letter Agreement. If such indemnification is
for any reason not available or insufficient to hold you harmless, we agree to
contribute to the Losses involved in such proportion as is appropriate to
reflect the relative benefits received by us and by you with respect to the
Engagement or, if such allocation is judicially determined unavailable, in such
proportions as is appropriate to reflect other equitable considerations such as
the relative fault of us on the one hand and of you on the other hand; provided
however, that, to the extent permitted by applicable law, the Indemnified
Persons shall not be responsible for amounts which in the aggregate are in
excess of the amount of all fees actually received by you from us in connection
with the Engagement. Relative benefits to us, on the one hand, and you on the
other hand, with respect to the Engagement shall be deemed to be in the same
proportion as (i) the total value paid or proposed to be paid or received or
proposed to be received by us or our security holders, as the case may be,
pursuant to the transactions), whether or not consummated, contemplated by the
Engagement bears to (ii) all fees paid or proposed to be paid to you by us in
connection with the Engagement.

         We will reimburse each Indemnified Person for all expenses (including
reasonable fees and disbursement of counsel) promptly after they are incurred
after submission to us of documentation related to the incurrence of such
expenses by such Indemnified Person in connection with investigating, preparing
for or defending any action, claim investigation, inquiry, arbitration or other
proceeding ("Action") referred to above (or enforcing this Agreement or any
related engagement Agreement), whether or not in connection with pending or
threatened litigation in which any Indemnified Person is a party, and whether or
not such Action is initiated or brought by you. We further agree that we will
not settle or compromise or consent to the entry of any judgment in any pending
or threatened Action in respect of which indemnification may be sought hereunder
(whether or not an indemnified Person is a party thereof) unless we have given
you reasonable prior written notice thereof and used all reasonable efforts,
after consultation with you, to obtain an unconditional release of each
Indemnified Person from all liability arising from the event thereof.

         In the event that we are called or subpoenaed to give testimony in a
court of law, you agree to pay our expenses related thereto and for every day or
part thereof that we are required to be there or in preparation thereof. Our
obligations hereunder shall be in addition to any rights that any Indemnified
Person may have at common law or otherwise. Solely for the purpose of enforcing
this Agreement, we hereby consent to personal jurisdiction on and to service and
venue in any court in which any claim which is subject to this Agreement is
brought by or against any Indemnified Person. We acknowledge that in connection
with this Engagement you are acting as an independent contractor with duties
owing solely to us. YOU HEREBY AGREE, AND WE HEREBY AGREE ON OUR OWN BEHALF AND,
TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF OUR SECURITY HOLDERS, TO
WAIVE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, COUNTER-CLAIM OR
ACTION ARISING OUT OF THE ENGAGEMENT, YOUR PERFORMANCE THEREOF OR THIS
AGREEMENT.

         The provisions of this Agreement shall Apply to the Engagement
(including related activities prior to the date hereof) and any modification
(hereof and shall remain in full force and effect regardless of the completion
or termination of the Engagement. This Agreement and any other Agreements
relating to the Engagement shall be governed by and construed in accordance with
the laws of the State of New York, without regard to conflicts of law principles
thereof.

                                             Very truly yours,

Accepted and Agreed;

Burnham Hill Partners,                       Client: A-Fem Medical Corporation
a Division of Pali Capital, Inc.

By: /s/Jason Adelman                         By: /s/Walter Witoshkin
    ----------------------------                 -------------------------------
    Name:  Jason Adelman                         Name:  Walter Witoshkin
    Title: Managing Director                     Title: Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]